Clinical Trials Logo

Chronic Hepatic Failure clinical trials

View clinical trials related to Chronic Hepatic Failure.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02310542 Completed - Clinical trials for Liver Failure, Acute

Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure

MARSPAD
Start date: December 2011
Phase: N/A
Study type: Interventional

A critical issue of the clinical syndrome in liver failure is the accumulation of toxins not cleared by the failing liver. Based on this hypothesis, albumin dialysis is used to remove those substances. Albumin dialysis with recirculation (MARS) is the most used system but required specific system and expert environment. Alternative system without recirculation (SPAD) is less expensive and can be realised in critical care services trained to extrarenal epuration. The primary objective of this study is to compare biological and clinical efficacy, pulsatility index of middle cerebral artery modification and tolerance of both systems. This is a prospective, open, cross-over comparative study of two albumin dialysis system. Each patient will receive the two systems in an randomly assessed order. Patients are divided up according to bilirubin plasmatic level. (250µmol/L to 400 µmol/L and >400µmol/L).